Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2000
PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidateM Bergström, C Juhlin, T A Bonasera, et al.
Bioconjugate Chemistry|November 24, 1999
Effects of dextranation on the pharmacokinetics of short peptides. A PET study on mEGFQ Zhao, V Tolmachev, J Carlsson, et al.
Medical Oncology (Northwood, London, England)|May 25, 2002
Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogsM L Fjällskog, A Sundin, J E Westlin, et al.
Journal of Endocrinological Investigation|March 25, 2010
The value of 11C-5-hydroxy-tryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience from one centerA Nikolaou, D Thomas, C Kampanellou, et al.
Nuclear Medicine and Biology|August 6, 2003
Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo-tumor visualization using positron emission tomography with 11C-harmineH Orlefors, A Sundin, K J Fasth, et al.
Yeast (Chichester, England)|July 30, 2004
Localization of proteins that are coordinately expressed with Cln2 during the cell cycleBryan A Sundin, Chun-Hwei Chiu, Michael Riffle, et al.
Work (Reading, Mass.)|February 10, 2012
Methodical aspects of text testing in a driving simulatorA Sundin, C J D Patten, M Bergmark, et al.
Nuclear Medicine and Biology|April 8, 2000
Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomographyA Sundin, B Eriksson, M Bergström, et al.
Nordisk Medicin|December 4, 1998
[PET in neuroendocrine tumors]B Eriksson, H Orlefors, A Sundin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 2011
The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapyC Suzuki, L Blomqvist, A Sundin, et al.
Pageof 12